Krebs Biochemicals & Industries Limited engages in the manufacture and sale of active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine, agriculture, and industry. Its products include androstenedione, lovastatin, and simvastatin, which are used for anti-cholesterol and steroid intermediate applications. The company also develops various products, including amlodipine, cetirizine, orlistat, serratiopepetidase, telmisartan, and phenylephrine for anti-hypertension, anti-histamine, anti-obesity, anti-inflammatory, and cold and cough applications. In addition, it offers contract manufacturing services for large pharmaceutical and multinational companies. The company was incorporated in 1991 and is based in Visakhapatnam, India.
Metrics to compare | KREB | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipKREBPeersSector | |
---|---|---|---|---|
P/E Ratio | −6.0x | 15.8x | −0.5x | |
PEG Ratio | 0.17 | 0.09 | 0.00 | |
Price/Book | −1.1x | 1.2x | 2.6x | |
Price / LTM Sales | 3.7x | 2.0x | 3.2x | |
Upside (Analyst Target) | - | 0.7% | 42.0% | |
Fair Value Upside | Unlock | 3.3% | 6.6% | Unlock |